We are live on ! Find out more
TMCI icon

Treace Medical Concepts

123 hedge funds and large institutions have $514M invested in Treace Medical Concepts in 2023 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 63 increasing their positions, 29 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more call options, than puts

Call options by funds: $1.76M | Put options by funds: $800K

117% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 29

0.19% more ownership

Funds ownership: 63.49%63.68% (+0.19%)

10% less funds holding

Funds holding: 137123 (-14)

37% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 38

48% less capital invested

Capital invested by funds: $996M → $514M (-$482M)

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
123
Holders Change
-14
Holders Change %
-10.22%
% of All Funds
1.95%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
24
Increased
63
Reduced
29
Closed
38
Calls
$1.76M
Puts
$800K
Net Calls
+$964K
Net Calls Change
-$1.55M
Name Holding Trade Value Shares
Change
Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$4.57M -$559K -30,545 -8%
Charles Schwab
27
Charles Schwab
California
$4.41M +$950K +51,892 +18%
Dimensional Fund Advisors
28
Dimensional Fund Advisors
Texas
$3.62M +$3.67M +200,654 +266%
SAM
29
Silvercrest Asset Management
New York
$3.57M +$883K +48,224 +22%
Wealth Enhancement Advisory Services
30
Wealth Enhancement Advisory Services
Minnesota
$3.28M +$4.58M +250,026 New
Renaissance Technologies
31
Renaissance Technologies
New York
$3.07M +$4.28M +234,000 New
PAMP
32
Polar Asset Management Partners
Ontario, Canada
$2.92M +$4.08M +222,671 New
FG
33
Formula Growth
Quebec, Canada
$2.91M +$1.91M +104,519 +89%
Morgan Stanley
34
Morgan Stanley
New York
$2.8M -$4.23M -231,152 -52%
Invesco
35
Invesco
Georgia
$2.35M +$2.98M +162,871 +988%
UOC
36
UBS O'Connor
Illinois
$2.27M +$1.11M +60,551 +54%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$2.18M +$55.8K +3,051 +2%
PI
38
Putnam Investments
Massachusetts
$2.15M -$1.92M -105,060 -39%
Neuberger Berman Group
39
Neuberger Berman Group
New York
$2.12M -$15.9K -870 -0.5%
Qube Research & Technologies (QRT)
40
Qube Research & Technologies (QRT)
United Kingdom
$2.1M +$1.74M +95,194 +146%
Alyeska Investment Group
41
Alyeska Investment Group
Illinois
$1.96M +$2.73M +149,366 New
Tudor Investment Corp
42
Tudor Investment Corp
Connecticut
$1.87M +$2.61M +142,530 New
GF
43
Gabelli Funds
New York
$1.85M +$1.19M +64,959 +85%
Walleye Capital
44
Walleye Capital
New York
$1.83M +$1.62M +88,239 +171%
Citadel Advisors
45
Citadel Advisors
Florida
$1.65M +$1.15M +62,571 +99%
Goldman Sachs
46
Goldman Sachs
New York
$1.6M +$97.2K +5,313 +5%
Squarepoint
47
Squarepoint
New York
$1.53M +$1.82M +99,359 +570%
Ameriprise
48
Ameriprise
Minnesota
$1.38M -$1.32M -72,324 -41%
First Trust Advisors
49
First Trust Advisors
Illinois
$1.34M -$105K -5,749 -5%
Swiss National Bank
50
Swiss National Bank
Switzerland
$1.33M +$262K +14,300 +16%

TMCI Hedge Fund Activity: Q3 2023 in Review

123 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Treace Medical Concepts (TMCI) for Q3 2023, worth a combined $514M — down 48% from $996M a quarter earlier.

Sellers outnumbered buyers: 38 funds closed out of TMCI and 24 opened new positions — a net loss of 14 holders — while 29 trimmed existing stakes and 63 added.

The largest buyer was Soleus Capital Management, opening a new position worth an estimated $34.9M. The largest seller was Next Century Growth Investors, cutting an estimated $19.6M.

  • 123 institutional investors held Treace Medical Concepts (TMCI) as of Q3 2023, down from 137 in Q2 2023.
  • Funds reported $514M of Treace Medical Concepts stock for Q3 2023, down 48% quarter-over-quarter.
  • 24 funds opened new Treace Medical Concepts positions in Q3 2023 and 38 closed out, a net change of -14 holders.
  • The largest Treace Medical Concepts buyer in Q3 2023 was Soleus Capital Management, an estimated $34.9M added.
  • The largest Treace Medical Concepts seller in Q3 2023 was Next Century Growth Investors, an estimated $19.6M sold.

Based on aggregated 13F filings for Q3 2023.